Amyloid PET, FDG-PET or MRI? - the power of different imaging biomarkers to detect progression of early Alzheimer’s disease

BACKGROUND: As investigations of disease modifying drugs aim to slow down progression of Alzheimer’ disease (AD) biomarkers to reliably track disease progression gain more importance. This is especially important as clinical symptoms, including psychometric measures, are only modestly associated wit...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Neurol
Main Authors: Ortner, Marion, Drost, René, Heddderich, Dennis, Goldhardt, Oliver, Müller-Sarnowski, Felix, Diehl-Schmid, Janine, Förstl, Hans, Yakushev, Igor, Grimmer, Timo
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2019
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6822351/
https://ncbi.nlm.nih.gov/pubmed/31672138
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12883-019-1498-9
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados